LP420302-4
Daratumumab
Active
Description
Daratumumab is a biologic drug used to treat multiple myeloma. It is a IgG1k human monoclonal antibody directed against CD38, a molecule present on myeloma cells. By binding to CD38, it inhibits the growth of CD38 expressing tumor cells and causes cell death by immune mediated tumor cell lysis PMID: 29915586. Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- Daratumumab
- Part Display Name
- Daratumumab
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2020-09-15
- Construct for LOINC Short Name
- Daratumumab
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| fr-FR | French (France) | Daratumumab |
| it-IT | Italian (Italy) | Daratumumab |
| es-ES | Spanish (Spain) | Daratumumab |
| zh-CN | Chinese (China) | 达雷妥尤单抗 Synonyms: 达雷木单抗; |
| nl-NL | Dutch (Netherlands) | daratumumab |
| el-GR | Greek (Greece) | Δαρατουμουμάμπη Synonyms: Δαρατουμουμάμπη |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://